Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 294-301, February 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, J. S.
Right arrow Articles by Morris, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, J. S.
Right arrow Articles by Morris, H. P.

Ribonuclease Activity in Some Transplantable Rat Hepatomas*

Jay S. Roth{dagger}, Sylvia Hilton and Harold P. Morris

( Institute of Cellular Biology, University of Connecticut, Storrs, Connecticut; and National Cancer Institute, Laboratory of Biochemistry, National Institutes of Health, Bethesda, Maryland)

Several parameters of ribonuclease activity have been determined in a series of transplantable rat tumors and liver from the host rats. These include ribonuclease inhibitor activity, pH activity curves, and the distribution and specific activity of acid and alkaline ribonuclease in subcellular fractions. For those hepatomas studied, compared with liver from the tumor-bearing animal, the following changes were observed: ribonuclease inhibitor in all hepatomas was lower (two exceptions); the percentage of acid and alkaline ribonuclease in the mitochondrial fraction was greatly lowered; the percentage of acid or alkaline ribonuclease in the nuclear fraction was either unchanged or elevated; the percentage of alkaline ribonuclease in the microsomal fraction was nearly doubled, and this was accompanied by a large increase in specific enzyme activity; and acid ribonuclease was considerably increased in the supernatant fraction. Many other changes were found but they were not observed in all the tumors.

* This project has been supported by grants from the National Cancer Institute, National Institutes of Health (C5264), and the American Cancer Society (P303). A preliminary report of some of this material was presented at the 142nd meeting of the American Chemical Society, Atlantic City, N.J., September, 1962.

{dagger} Supported by a Public Health Service Research Career Program award (RC 31–63) from the National Cancer Institute, National Institutes of Health.

Received 8/16/63.


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. C. Haigis, E. L. Kurten, and R. T. Raines
Ribonuclease inhibitor as an intracellular sentry
Nucleic Acids Res., February 1, 2003; 31(3): 1024 - 1032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.